share_log

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%

空头股数在Q生物医药公司(OTCMKTS:QBIO)下跌99.5%
kopsource ·  2022/07/29 16:11

Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% from the June 30th total of 19,200 shares. Based on an average daily trading volume, of 844,800 shares, the short-interest ratio is currently 0.0 days.

Q BioMed Inc.(场外交易代码:QBIO-GET Rating)是7月份空头股数价格大幅下降的接收方。截至7月15日,空头股数共有100股,与6月30日的19,200股相比,下降了99.5%。以日均成交量844,800股计算,目前短息比为0.0天。

Q BioMed Price Performance

Q BioMed性价比

Shares of QBIO traded down $0.01 during mid-day trading on Friday, hitting $0.17. 453,350 shares of the company's stock were exchanged, compared to its average volume of 234,883. The company has a market cap of $7.05 million, a PE ratio of -0.55 and a beta of 1.74. Q BioMed has a 52 week low of $0.04 and a 52 week high of $0.90. The company has a 50-day simple moving average of $0.08 and a 200 day simple moving average of $0.22.

QBIO的股价在周五午盘交易中下跌0.01美元,触及0.17美元。该公司股票成交量为453,350股,而其平均成交量为234,883股。该公司市值为705万美元,市盈率为-0.55,贝塔系数为1.74。Q BioMed的52周低点为0.04美元,52周高点为0.90美元。该公司的50日简单移动均线切入位在0.08美元,200日简单移动均线切入位在0.22美元。

Get
到达
Q BioMed
Q BioMed
alerts:
警报:

About Q BioMed

关于Q BioMed

(Get Rating)

(获取评级)

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc.是一家生物医学加速和开发公司,专注于许可、收购和向生命科学和医疗保健公司提供资源。该公司提供氯化锶SR89和美沙酮,这是一种治疗转移性骨癌疼痛的放射性药物。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
  • The One Question You Have to Ask Before Investing in INTC Stock
  • Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
  • Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
  • Why Apple Shares May Have Room to Move Higher After Earnings
  • Windfall Profits Have Exxon Mobil On Track For New Highs
  • 免费获取有关Q BioMed(QBIO)的StockNews.com研究报告
  • 在投资INTC股票之前,你必须问一个问题
  • 家得宝:引领熊市的美丽而乏味的股票
  • CRISPR治疗公司可能是隐藏在平坦视线中的登月计划吗?
  • 为什么苹果股价在盈利后有走高的空间
  • 暴利使埃克森美孚有望创下新高

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.

接受Q BioMed Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Q BioMed和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发